Loading clinical trials...

COMPLETEDPhase 2NCT03946449

Study of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)

The purpose of this study is to evaluate the the safety and efficacy of the investigational product, fazirsiran (TAK-999, ARO-AAT), administered subcutaneously to patients with alpha-1 antitrypsin def...

Lead sponsor: Arrowhead Pharmaceuticals•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 1/2

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

NCT06389877 · Alpha 1-Antitrypsin Deficiency

RECRUITINGPhase 1

Gene Therapy for Alpha 1- Antitrypsin Deficiency

NCT06996756 · Alpha 1-Antitrypsin Deficiency

RECRUITING

Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction

NCT07152834 · Alpha 1-antitrypsin Deficiency (AATD)

RECRUITINGPhase 3

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

NCT04204252 · Alpha 1-Antitrypsin Deficiency

RECRUITING

Alpha-1 Research Registry

NCT04157049 · Alpha 1-Antitrypsin Deficiency

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 15, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment16

Start dateOct 2019

Last updatedOct 15, 2025

Condition

Alpha 1-Antitrypsin Deficiency

Locations shown

Research Center 1

Vienna

Research Center 1

Aachen

Research Center 3

Cambridge

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 15, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions